...Beta-T cell receptor (T(β) rec) gene rearrangements in the molecular analysis of T cell populations Beta-zone...
http://vivo.med.cornell.edu/individuallist?page=457&vclassId=http%3A%2F%2Fpurl.org%2Fontology%2Fbibo%2FAcademicArticle
...in advanced cancer patients is not normalized by tyrosine kinase inhibition of the vascular endothelial...
http://vivo.med.cornell.edu/individuallist?page=1154&vclassId=http%3A%2F%2Fpurl.org%2Fontology%2Fbibo%2FArticle
...Actuality) Enhancing hematopoietic growth factor performance Enlightening the impact of immunogenic cell...
http://vivo.med.cornell.edu/individuallist?page=32&vclassId=http%3A%2F%2Fweill.cornell.edu%2Fvivo%2Fontology%2Fwcmc%23Comment
...tumors in vivo IL-12-secreting CD19-targeted cord blood-derived T cells for the immunotherapy of B-cell...
http://vivo.med.cornell.edu/individuallist?page=1572&vclassId=http%3A%2F%2Fpurl.org%2Fontology%2Fbibo%2FAcademicArticle
...intrahepatic injection of CD34+human (h) cord blood (CB) cells Academic Article Human T cell L-plastin...
http://vivo.med.cornell.edu/individuallist?page=1995&vclassId=http%3A%2F%2Fpurl.org%2Fontology%2Fbibo%2FArticle
...Sphingosine 1-phosphate-induced endothelial cell migration requires the expression of EDG-1 and EDG-3...
https://pathology.weill.cornell.edu/research/publications?page=430
...cell and anti-vascular smooth muscle cell antibodies in patients with giant cell arteritis: A proteomic...
http://vivo.med.cornell.edu/individuallist?page=2034&vclassId=http%3A%2F%2Fpurl.org%2Fontology%2Fbibo%2FArticle
...proliferation in endothelial cells Academic Article Fatty acid chain is a critical epitope for antiphospholipid...
http://vivo.med.cornell.edu/individuallist?page=1688&vclassId=http%3A%2F%2Fpurl.org%2Fontology%2Fbibo%2FArticle
...Cell Rep. 43(6):114278....
https://brainandmind.weill.cornell.edu/faculty-research/publications?page=13&s=author&o=desc
...progenitor cells in the bone marrow, was labeled with α-particle-emitting Ac....
https://mdphd.weill.cornell.edu/alumni/alumni-publications/vascular-targeted-radioimmunotherapy-treatment-glioblastoma